Provided by Tiger Fintech (Singapore) Pte. Ltd.

DexCom

66.33
+0.22000.33%
Post-market: 67.461.13+1.70%19:52 EDT
Volume:4.14M
Turnover:274.90M
Market Cap:26.01B
PE:46.58
High:67.31
Open:67.09
Low:65.53
Close:66.11
Loading ...

Dexcom’s Resilience Amid Manufacturing Challenges: A Buy Rating Affirmation

TIPRANKS
·
10 Mar

DexCom sees no material impact from warning letter on sales outlook

TIPRANKS
·
09 Mar

Wells sees no material impact from DexCom warning letter

TIPRANKS
·
09 Mar

DexCom warning letter ‘not thesis changing,’ says BofA

TIPRANKS
·
09 Mar

Dexcom’s Resilience Amid FDA Warning: Buy Rating Affirmed by Analyst

TIPRANKS
·
08 Mar

Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?

Insider Monkey
·
08 Mar

Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop

Simply Wall St.
·
08 Mar

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

Reuters
·
08 Mar

BUZZ-Dexcom falls after FDA's warning letter over deficiencies at two facilities

Reuters
·
08 Mar

DexCom Gets FDA Warning Letter After Inspections of Facilities

Dow Jones
·
08 Mar

DexCom falls 7% to $71.99 after receiving warning letter from FDA

TIPRANKS
·
08 Mar

BRIEF-Dexcom Inc Does Not Expect Material Impact From FDA Warning Letter

Reuters
·
08 Mar

Dexcom Inc - FDA Cites Deficiencies in Dexcom's Response Letters

THOMSON REUTERS
·
08 Mar

Dexcom Inc: on March 4 Received Warning Letter From FDA Following Inspections of Co’s Facilities in San Diego, California, & Mesa, Arizona

THOMSON REUTERS
·
08 Mar

Dexcom Inc - Does Not Expect Material Impact From FDA Warning Letter

THOMSON REUTERS
·
08 Mar

DexCom Receives US FDA Warning After Inspections

MT Newswires Live
·
08 Mar

DexCom receives warning letter from FDA, sees no impact to FY25 guidance

TIPRANKS
·
08 Mar

DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Mar

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2025-03-04

Reuters
·
05 Mar

DexCom Is Maintained at Buy by Citigroup

Dow Jones
·
05 Mar